Topic: Anadys Pharmaceuticals Inc.
Anadys Pharmaceuticals says hepatitis C drug candidate shows potential in early studyAnadys Pharmaceuticals Inc. said Tuesday its hepatitis C drug candidate ANA-773 could be extremely effective at treating the diseases.The statement is based on early-stage study data, which is only typically good ...
Anadys Pharmaceuticals gets FDA clearance to begin study on hepatitis C therapyAnadys Pharmaceuticals Inc. said Thursday the Food and Drug Administration cleared the company's plan for a midstage study on a potential combination therapy for hepatitis C.The combination includes the drug candidate ...
